Lucozade and Ribena are well-loved in Britain, but lack global reach, especially in the big emerging markets that are becoming the focus of the British drug maker’s consumer health business
Trending
- Breaking: IGP deploys 38 CPs to Commands, Formations
- Dominion City set to host Camp Meeting 2025
- Insecurity: Governor urges FG to prohibit open grazing nationwide
- False Declaration: MMIA Customs hands over $578,000 to EFCC
- Lagos telecom operators lose N5b to fibre cuts in 2024
- World Oral Health Day: Oyo, Aspira call for improved dental care
- WCQ: Osimhen’s brace lifts Nigeria above Rwanda in Kigali
- Kukah inaugurated as chairman Southern Kaduna varsity